About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,824 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,824 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4821-4840 of 10,824 trials

Not yet recruitingImpact of Dysport on PMFF Donor ScarThe purpose of this research study is to investigate the effect of pre-operative injections of Dysport (Abobotulinumtoxin-A, commonly known as "Botox") on the cosmetic appearance…NCT07720726·Nashville, Tennessee CompletedCombined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular LymphomaThe purpose of this study is to evaluate the effect of the combined treatment of lenalidomide and rituximab in controlling the Follicular Lymphoma disease and also increase the…NCT01476787·Chandler, Arizona and 35 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

Active not recruitingAZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.To assess the efficacy and safety of AZD9291 versus Placebo, in patients with Epidermal Growth Factor Receptor Mutation Positive stage IB-IIIA non-small cell lung carcinoma…NCT02511106·Los Angeles, California and 237 others

CompletedImpact of Medical Treatment on Sexual Function in Patients With Crohn's DiseaseCrohn's disease is a chronic inflammatory condition of the intestines that causes abdominal pain, diarrhea, tunnels around the anus (fistulas), and extraintestinal symptoms.NCT02619552·Baltimore, Maryland and 3 others

CompletedStudy of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic MalformationsOBJECTIVES: I. Determine the efficacy of picibanil sclerotherapy in children with macrocystic lymphangioma.NCT00010452·San Diego, California and 12 others

UnknownIfetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceThis pilot trial studies the side effects of ifetroban in treating patients with malignant solid tumors that are at high risk of coming back after treatment and spreading…NCT03694249·Nashville, Tennessee

CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19 starting intervention within 3 days of…NCT05305547·Guntersville, Alabama and 195 others

CompletedTreatment for Migraines With an Implantable DeviceThe purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine.NCT00286078·Denver, Colorado and 14 others

CompletedEffectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic SyndromeHypothesis: 3,4-Diaminopyridine base (3,4-DAP) improves Lambert-Eaton Myasthenic Syndrome (LEMS)-related weakness.NCT01511978·Sacramento, California and 6 others

CompletedA Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.Primary objective • To evaluate the efficacy of 5 μg/mL and 10 μg/mL concentrations of the new formulation of rhNGF ophthalmic solution versus vehicle, in order to demonstrate…NCT06244316·Chandler, Arizona and 13 others

CompletedEvaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected AdultsThis study will evaluate the safety and immune response to the DNA-HIV-PT123 vaccine used in combination with one of two protein vaccines (Bivalent Subtype C gp120/MF59 or…NCT02915016·Birmingham, Alabama and 16 others

TerminatedA Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsOpen-label, multi-center, multi-national rollover study to allow continued access to tivozanib for subjects who have participated in other tivozanib (monotherapy or combination)…NCT01369433·Scottsdale, Arizona and 48 others

CompletedLow-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway GliomaThis randomized phase II trial studies how well low-dose lenalidomide works compared with high-dose lenalidomide in treating younger patients with juvenile pilocytic astrocytomas…NCT01553149·Birmingham, Alabama and 125 others

TerminatedCMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaCMP-001-007 is a Phase 2 study of CMP-001 intratumoral (IT) and pembrolizumab intravenous (IV) administered to participants with head and neck squamous cell carcinoma (HNSCC) who…NCT04633278·Little Rock, Arkansas and 18 others

CompletedEfficacy and Safety Study of Clonidine Lauriad® to Treat Oral MucositisThe purpose of this study is to evaluate the efficacy and safety of Clonidine Lauriad® to treat chemoradiation therapy induced severe oral mucositis in patients with head and neck…NCT01385748·Sun City, Arizona and 50 others

RecruitingA Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With EzabenlimabThis study is open to adults with advanced cancer.NCT07607678·New Haven, Connecticut and 8 others

CompletedA Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue SarcomaThe main purpose of this study is to evaluate the efficacy of the combination of doxorubicin plus the study drug known as olaratumab versus doxorubicin plus placebo in…NCT02451943·Duarte, California and 113 others

CompletedVolasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)To investigate the efficacy, safety, and pharmacokinetics of intravenous volasertib + subcutaneous low dose cytarabine in patients \>= 65 years of age with previously untreated…NCT01721876·Los Angeles, California and 121 others

CompletedStudy of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative ColitisUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).NCT05570006·Chula Vista, California and 29 others

Active not recruitingTesting the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyThis phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with…NCT04248452·Anchorage, Alaska and 452 others

PreviousPage 242 of 542Next

Diabetes

in Nashville

Heart Diseasein Nashville